These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 20515470)

  • 61. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
    Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
    Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc.
    Zhang C; Zhang S; Zhang Z; He J; Xu Y; Liu S
    Oncogene; 2014 Dec; 33(49):5582-91. PubMed ID: 24317511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
    Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
    Shen H; Zhao L; Feng X; Xu C; Li C; Niu Y
    Oncotarget; 2016 Sep; 7(37):60407-60418. PubMed ID: 27494865
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1.
    Gu H; Liu M; Ding C; Wang X; Wang R; Wu X; Fan R
    Cancer Med; 2016 Jun; 5(6):1174-82. PubMed ID: 26990493
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells.
    Sarveswaran S; Ghosh R; Parikh R; Ghosh J
    Mol Cancer Ther; 2016 Nov; 15(11):2791-2801. PubMed ID: 27474149
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
    Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
    Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
    Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
    Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
    Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
    Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A long noncoding RNA connects c-Myc to tumor metabolism.
    Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis.
    Wu L; Xia L; Chen X; Ruan M; Li L; Xia R
    Leuk Res; 2021 Jul; 106():106565. PubMed ID: 33865032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.
    Qiu X; Boufaied N; Hallal T; Feit A; de Polo A; Luoma AM; Alahmadi W; Larocque J; Zadra G; Xie Y; Gu S; Tang Q; Zhang Y; Syamala S; Seo JH; Bell C; O'Connor E; Liu Y; Schaeffer EM; Jeffrey Karnes R; Weinmann S; Davicioni E; Morrissey C; Cejas P; Ellis L; Loda M; Wucherpfennig KW; Pomerantz MM; Spratt DE; Corey E; Freedman ML; Shirley Liu X; Brown M; Long HW; Labbé DP
    Nat Commun; 2022 May; 13(1):2559. PubMed ID: 35562350
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metformin targets c-MYC oncogene to prevent prostate cancer.
    Akinyeke T; Matsumura S; Wang X; Wu Y; Schalfer ED; Saxena A; Yan W; Logan SK; Li X
    Carcinogenesis; 2013 Dec; 34(12):2823-32. PubMed ID: 24130167
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts.
    Santio NM; Eerola SK; Paatero I; Yli-Kauhaluoma J; Anizon F; Moreau P; Tuomela J; Härkönen P; Koskinen PJ
    PLoS One; 2015; 10(6):e0130340. PubMed ID: 26075720
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PIM1: a promising target in patients with triple-negative breast cancer.
    Zhao W; Qiu R; Li P; Yang J
    Med Oncol; 2017 Aug; 34(8):142. PubMed ID: 28721678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.